The chemical substance with the name "Cyclo[D-alanyl-2,3-didehydroalanyl-N-methylglycyl-2-[(1R)-1-aminoethyl]-4-thiazolecarbonyl-L-tryptophyl-4-methoxy-L-tryptophylglycyl]" and CAS number 174423-37-1 is a complex cyclic peptide. Its structure incorporates multiple amino acids and functional groups, which contribute to its unique properties. The presence of thiazole and tryptophan residues suggests potential biological activity, possibly related to interactions with receptors or enzymes. The cyclic nature of the compound may enhance its stability and bioavailability compared to linear peptides. Additionally, the incorporation of non-standard amino acids, such as 2,3-didehydroalany and N-methylglycine, can influence its conformational flexibility and binding affinity. This compound may exhibit specific pharmacological effects, making it of interest in medicinal chemistry and drug development. However, detailed studies would be necessary to elucidate its mechanism of action, potential therapeutic applications, and safety profile. As with many peptides, solubility, stability, and reactivity are critical factors that would influence its practical use in biological systems.

Cyclo[D-alanyl-2,3-didehydroalanyl-N-methylglycyl-2-[(1R)-1-aminoethyl]-4-thiazolecarbonyl-L-tryptophyl-4-methoxy-L-tryptophylglycyl]

174423-37-1: The chemical substance with the name "Cyclo[D-alanyl-2,3-didehydroalanyl-N-methylglycyl-2-[(1R)-1-aminoethyl]-4-thiazolecarbonyl-L-tryptophyl-4-methoxy-L-tryptophylglycyl]" and CAS number 174423-37-1 is a complex cyclic peptide. Its structure incorporates multiple amino acids and functional groups, which contribute to its unique properties. The presence of thiazole and tryptophan residues suggests potential biological activity, possibly related to interactions with receptors or enzymes. The cyclic nature of the compound may enhance its stability and bioavailability compared to linear peptides. Additionally, the incorporation of non-standard amino acids, such as 2,3-didehydroalany and N-methylglycine, can influence its conformational flexibility and binding affinity. This compound may exhibit specific pharmacological effects, making it of interest in medicinal chemistry and drug development. However, detailed studies would be necessary to elucidate its mechanism of action, potential therapeutic applications, and safety profile. As with many peptides, solubility, stability, and reactivity are critical factors that would influence its practical use in biological systems.

<p>Argyrin A is a cyclic peptide and potent antitumor agent. It functions by inhibiting the proteasome (proteasome), leading to increased levels of endogenous p27kip1 by preventing protein turnover.</p>

CAS 174423-37-1

Cyclo[D-alanyl-2,3-didehydroalanyl-N-methylglycyl-2-[(1R)-1-aminoethyl]-4-thiazolecarbonyl-L-tryptophyl-4-methoxy-L-tryptophylglycyl]

Argyrin A

Ref: TM-TN9118